Details for New Drug Application (NDA): 203478
✉ Email this page to a colleague
The generic ingredient in RIZATRIPTAN BENZOATE is rizatriptan benzoate. There are twenty-two drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the rizatriptan benzoate profile page.
Summary for 203478
Tradename: | RIZATRIPTAN BENZOATE |
Applicant: | Natco Pharma Ltd |
Ingredient: | rizatriptan benzoate |
Patents: | 0 |
Pharmacology for NDA: 203478
Mechanism of Action | Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists |
Suppliers and Packaging for NDA: 203478
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
RIZATRIPTAN BENZOATE | rizatriptan benzoate | TABLET, ORALLY DISINTEGRATING;ORAL | 203478 | ANDA | Breckenridge Pharmaceutical, Inc. | 51991-362 | 51991-362-78 | 3 BLISTER PACK in 1 CARTON (51991-362-78) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (51991-362-99) |
RIZATRIPTAN BENZOATE | rizatriptan benzoate | TABLET, ORALLY DISINTEGRATING;ORAL | 203478 | ANDA | Breckenridge Pharmaceutical, Inc. | 51991-363 | 51991-363-78 | 3 BLISTER PACK in 1 CARTON (51991-363-78) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (51991-363-99) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | EQ 5MG BASE | ||||
Approval Date: | Jul 1, 2013 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | EQ 10MG BASE | ||||
Approval Date: | Jul 1, 2013 | TE: | AB | RLD: | No |
Complete Access Available with Subscription